Learn Before
Findings supporting heparin use in COVID-19 patients for patients at high risk of coagulopathy from retrospective study in Wuhan, China
SIC score and diagnostics for evaluating heparin effectiveness in COVID-19 patients for patients at high risk of coagulopathy from retrospective study in Wuhan, China
SIC score interpretation for COVID-19
SIC stands for sepsis‐induced coagulopathy, which sometimes precedes disseminated intravascular congestion (DIC) where clotting throughout the body can diminish organ function. It is often associated with sepsis and severe inflammatory response, often as a result of infections, such as COVID-19. Additionally, many autopsies of COVID-19 fatalities found evidence of DIC.
SIC scores are a way to evaluate patients' risk of developing DIC and suggest the best course of treatment. Recommend treatments may also help COVID-19 patients.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Differences in 28-day mortality of severe COVID-19 patients treated with unfractionated heparin or low molecular weight heparin (LMWH) compared to control group given no anticoagulant based on SIC score
Differences in 28-day mortality of severe COVID-19 patients by D-dimer level among those given unfractionated heparin or low molecular weight heparin (LMWH) compared to control group given no anticoagulant.
Evaluation of other predictors of 28-day mortality pertaining to clotting factors and heparin treatment
SIC score interpretation for COVID-19
Methods for evaluating heparin effectiveness in COVID-19 patients for patients at high risk of coagulopathy from retrospective study in Wuhan, China
Patient characteristics in study evaluating heparin effectiveness in COVID-19 patients for patients at high risk of coagulopathy from retrospective study in Wuhan, China
Discussion for evaluating 28-day mortality of severe COVID-19 patients treated with unfractionated heparin or low molecular weight heparin (LMWH) compared to control group
SIC score interpretation for COVID-19